BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
LPL Financial
LPLA
$28.3B
| $363M | 0.01% |
3,937,311
-88,285
| -2% | -$7.58M |
|
1052
Korn Ferry
KFY
$4.28B
| $362M | 0.01% |
8,542,557
+238,610
| +3% | +$9.22M |
|
1053
Meritage Homes
MTH
$4.76B
| $362M | 0.01% |
11,842,460
+69,394
| +0.6% | +$2.38M |
|
1054
Franklin Electric
FELE
$4.84B
| $362M | 0.01% |
6,308,234
+138,558
| +2% | +$7.32M |
|
1055
Coherent
COHR
$75B
| $361M | 0.01% |
10,733,468
-1,540,287
| -13% | -$49.1M |
|
1056
UMB Financial
UMBF
$11.1B
| $361M | 0.01% |
5,257,769
+15,479
| +0.3% | +$1.03M |
|
1057
Rollins
ROL
$18B
| $361M | 0.01% |
16,314,896
+240,408
| +1% | +$5.7M |
|
1058
Axalta
AXTA
$8.13B
| $360M | 0.01% |
11,845,217
+797,519
| +7% | +$23.5M |
|
1059
CNO Financial Group
CNO
$5.07B
| $359M | 0.01% |
19,823,707
-199,954
| -1% | -$3.4M |
|
1060
Fabrinet
FN
$20.3B
| $358M | 0.01% |
5,523,422
+97,897
| +2% | +$5.66M |
|
|
EPAY
1061
DELISTED
Bottomline Technologies Inc
EPAY
| $357M | 0.01% |
6,668,163
+710,968
| +12% | +$32.3M |
|
1062
Kennametal
KMT
$2.53B
| $357M | 0.01% |
9,666,180
+128,926
| +1% | +$4.32M |
|
1063
SLM Corp
SLM
$5.13B
| $356M | 0.01% |
39,923,855
-256,411
| -0.6% | -$2.23M |
|
1064
Bread Financial
BFH
$4.39B
| $356M | 0.01% |
3,970,464
+103,315
| +3% | +$9.13M |
|
1065
iShares 20+ Year Treasury Bond ETF
TLT
$41.6B
| $355M | 0.01% |
2,623,990
-203,833
| -7% | -$28.4M |
|
|
MRTX
1066
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $355M | 0.01% |
2,756,699
+23,429
| +0.9% | +$2.26M |
|
|
ROIC
1067
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $355M | 0.01% |
20,093,002
+565,886
| +3% | +$10.2M |
|
1068
EXL Service
EXLS
$5.27B
| $355M | 0.01% |
25,535,860
+259,765
| +1% | +$3.55M |
|
1069
Teva Pharmaceuticals
TEVA
$41.2B
| $353M | 0.01% |
36,064,323
+526,979
| +1% | +$4.7M |
|
1070
Bath & Body Works
BBWI
$4.09B
| $353M | 0.01% |
24,091,714
-1,893,899
| -7% | -$27.3M |
|
1071
BWX Technologies
BWXT
$15.6B
| $352M | 0.01% |
5,662,466
-1,681
| -0% | -$99.9K |
|
1072
The Ensign Group
ENSG
$10.6B
| $351M | 0.01% |
7,745,580
-409,564
| -5% | -$17.3M |
|
1073
Eagle Materials
EXP
$6.54B
| $351M | 0.01% |
3,875,911
+14,697
| +0.4% | +$1.35M |
|
|
FMBI
1074
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $351M | 0.01% |
15,235,535
-1,010,092
| -6% | -$21.5M |
|
1075
Invesco Senior Loan ETF
BKLN
$6.81B
| $351M | 0.01% |
15,392,746
+1,974,101
| +15% | +$44.5M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.